Commonwealth Equity Services’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-13,433
| Closed | -$13K | – | 4087 |
|
|
2024
Q3 | $13K | Sell |
13,433
-6,762
| -33% | -$6.54K | ﹤0.01% | 4022 |
|
|
2024
Q2 | $20K | Buy |
20,195
+3,849
| +24% | +$3.81K | ﹤0.01% | 3969 |
|
|
2024
Q1 | $26K | Sell |
16,346
-412
| -2% | -$655 | ﹤0.01% | 3944 |
|
|
2023
Q4 | $13K | Sell |
16,758
-15,117
| -47% | -$11.7K | ﹤0.01% | 3845 |
|
|
2023
Q3 | $25K | Hold |
31,875
| – | – | ﹤0.01% | 3716 |
|
|
2023
Q2 | $29K | Buy |
+31,875
| New | +$29K | ﹤0.01% | 3721 |
|
|
2020
Q3 | – | Sell |
-28,500
| Closed | -$285K | – | 3047 |
|
|
2020
Q2 | $285K | Buy |
+28,500
| New | +$285K | ﹤0.01% | 2310 |
|